Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05806931
Title Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer (SCOTI)
Acronym SCOTI
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Trinitas Hospital and Comprehensive Cancer Center RECRUITING Elizabeth New Jersey 07202 United States Details
RWJBarnabas Health Jersey City Medical Center RECRUITING Jersey City New Jersey 07302 United States Details
RWJBarnabas Health - Monmouth Medical Center Southern Campus RECRUITING Lakewood New Jersey 08701 United States Details
Cooperman Barnabas Medical Center (Saint Barnabas Medical Center) RECRUITING Livingston New Jersey 07039 United States Details
RWJBarnabas Health - Monmouth Medical Center RECRUITING Long Branch New Jersey 07740 United States Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08903 United States Details
RWJBarnabas Health - Robert Wood Johnson University Hospital RECRUITING New Brunswick New Jersey 08903 United States Details
RWJBarnabas Health - Robert Wood Johnson University Hospital RECRUITING Somerset New Jersey 08873 United States Details
RWJBarnabas Health - Community Medical Center RECRUITING Toms River New Jersey 08755 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field